Within the context of the opioid crisis, improving care for patients experiencing pain, from acute to chronic, has been the focus of multiple stakeholders.1 Chronic pain alone affects approximately 20% of US adults, and many people experiencing pain do not get optimal relief despite a wide variety of nonopioid, opioid, and nonpharmacologic treatments due to limited evidence, inadequate access, and health disparities.1,2 Although release of the 2016 Centers for Disease Control and Prevention (CDC) guideline for prescribing opioids for chronic pain was associated with fewer opioid prescriptions, there was also an association with decreased access to opioids, abandonment, and abrupt discontinuation.3,4